Effect of Vaginal PH on Treatment Effectiveness With Misoprostol for First Trimester Missed Abortions
NCT ID: NCT01270334
Last Updated: 2011-01-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
400 participants
OBSERVATIONAL
2011-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Vaginal Misoprostol In Medical Treatment of First Trimester Missed Miscarriage
NCT05094375
Study of Effect of Vaginal ph and Acidification of Vaginal Misoprostol on Its Efficacy for Induction of Midtrimester Abortion
NCT01241045
Vaginal Misoprostol In Management Of First Trimester Missed Abortion.
NCT03148314
Dilation and Curettage Versus Operative Hysteroscopy for Missed Abortion
NCT04705324
Misoprostol in Termination of First Trimester Missed Abortion
NCT00797693
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ph above cutoff
PH meassurment
meassuring ph USING PROBE
PH under cutoff
PH meassurment
meassuring ph USING PROBE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
PH meassurment
meassuring ph USING PROBE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
HaEmek Medical Center, Israel
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
HaEmek Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Haemel Medical Center
Afula, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
shira baram, md
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
cytoph
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.